哈药股份
(600664)
| 流通市值：205.01亿 | | | 总市值：205.01亿 |
| 流通股本：25.19亿 | | | 总股本：25.19亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 8,295,656,520.47 | 4,175,172,325.87 | 15,964,064,818.53 | 12,021,256,198.55 |
| 营业总成本 | 7,791,338,229.06 | 3,962,817,877.77 | 15,347,569,067.04 | 11,509,872,116.8 |
| 其他经营收益 | | | | |
| 营业利润 | 521,002,632.66 | 208,137,427.93 | 586,026,743.33 | 485,706,547.04 |
| 利润总额 | 517,858,470.2 | 206,432,431.56 | 572,738,622.08 | 481,039,085.87 |
| 净利润 | 409,075,631.91 | 161,071,923.96 | 398,777,512.49 | 341,694,663.14 |
| 每股收益 | | | | |
| 其他综合收益 | 516,936.15 | 33,249.11 | -2,503,704.81 | 297,097.02 |
| 综合收益总额 | 409,592,568.06 | 161,105,173.07 | 396,273,807.68 | 341,991,760.16 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 11,054,993,529.94 | 11,037,959,035.16 | 10,653,020,066.08 | 10,513,538,495.73 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,580,472,215.04 | 3,614,581,728.17 | 3,634,639,324.79 | 3,567,326,980.01 |
| 资产总计 | 14,635,465,744.98 | 14,652,540,763.33 | 14,287,659,390.87 | 14,080,865,475.74 |
| 流动负债: | | | | |
| 流动负债合计 | 7,333,599,210.96 | 7,610,502,914.98 | 7,422,587,268.83 | 7,275,951,663.7 |
| 非流动负债: | | | | |
| 非流动负债合计 | 417,277,858.51 | 405,936,567.83 | 402,976,930.48 | 397,100,668.01 |
| 负债合计 | 7,750,877,069.47 | 8,016,439,482.81 | 7,825,564,199.31 | 7,673,052,331.71 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 6,105,875,251.15 | 5,860,019,884.88 | 5,688,095,822.23 | 5,657,894,078.79 |
| 股东权益合计 | 6,884,588,675.51 | 6,636,101,280.52 | 6,462,095,191.56 | 6,407,813,144.03 |
| 负债和股东权益合计 | 14,635,465,744.98 | 14,652,540,763.33 | 14,287,659,390.87 | 14,080,865,475.74 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 8,476,798,405.22 | 3,891,995,694 | 16,848,265,358.73 | 12,222,291,791.9 |
| 经营活动现金流出小计 | 8,523,065,187.13 | 4,078,055,943.97 | 16,408,609,315.61 | 12,556,010,302.51 |
| 经营活动产生的现金流量净额 | -46,266,781.91 | -186,060,249.97 | 439,656,043.12 | -333,718,510.61 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 62,874,888.06 | 27,490 | 7,858,969.58 | 6,641,177.68 |
| 投资活动现金流出小计 | 63,801,176.9 | 21,172,024.46 | 150,946,595.5 | 97,021,273.09 |
| 投资活动产生的现金流量净额 | -926,288.84 | -21,144,534.46 | -143,087,625.92 | -90,380,095.41 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 737,079,588.75 | 345,331,018.06 | 1,346,546,616.46 | 1,211,889,963.95 |
| 筹资活动现金流出小计 | 704,254,091.33 | 369,878,333.95 | 1,803,736,343.11 | 1,621,753,684.62 |
| 筹资活动产生的现金流量净额 | 32,825,497.42 | -24,547,315.89 | -457,189,726.65 | -409,863,720.67 |
| 汇率变动对现金及现金等价物的影响 | -2,660,398.4 | -1,708,743.27 | -2,691,109.82 | -1,152,377.39 |
| 现金及现金等价物净增加额 | -17,027,971.73 | -233,460,843.59 | -163,312,419.27 | -835,114,704.08 |
| 期末现金及现金等价物余额 | 3,346,017,297.67 | 3,129,584,425.81 | 3,363,045,269.4 | 2,691,242,984.59 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -17,027,971.73 | - | -163,312,419.27 | - |
最新报告期：2026-08-26| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 华泰证券 | 代雯,唐庆雷,张云逸 | 0.24 | 0.28 | 0.32 | 2026-08-26 |